Gintarinė vaistinė - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 118,752,218 | 134,066,146 | 147,760,719 | 167,275,863 | 197,660,941 | 221,443,961 | 246,236,573 | 285,633,117 |
| Profit before tax | 4,902,904 | 6,164,140 | 5,947,388 | 7,103,659 | 6,555,011 | 3,519,881 | 3,862,673 | 3,257,134 |
| Net profit | 4,189,240 | 5,323,858 | 4,910,903 | 5,935,792 | 5,586,920 | 2,900,520 | 3,186,670 | 2,836,553 |
| Equity | 10,026,506 | 11,328,443 | 10,826,359 | 12,075,494 | 11,775,568 | 9,146,176 | 9,228,937 | 8,873,820 |
| Liabilities | 17,118,505 | 23,413,415 | 27,478,198 | 24,936,303 | 34,109,227 | 22,383,690 | 27,576,553 | 40,689,919 |
| Non-current assets | 5,601,000 | 10,287,118 | 4,975,680 | 9,917,655 | 5,068,500 | 4,698,888 | 4,035,287 | 3,959,796 |
| Current assets | 22,454,524 | 25,777,577 | 34,932,283 | 29,442,288 | 42,487,420 | 27,912,348 | 33,762,233 | 47,113,237 |
| Total assets | 28,055,524 | 36,064,695 | 39,907,963 | 39,359,943 | 47,555,920 | 32,611,236 | 37,797,520 | 51,073,033 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 8,035,127 | 8,689,099 | 9,696,834 |
| Social insurance contributions | - | - | - | - | - | 5,768,937 | 6,764,682 | 7,410,336 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +4.9% | +12.9% | +10.2% | +13.2% | +18.2% | +12.0% | +11.2% | +16.0% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 14.9% | 14.8% | 12.3% | 15.1% | 11.7% | 8.9% | 8.4% | 5.6% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 41.8% | 47.0% | 45.4% | 49.2% | 47.4% | 31.7% | 34.5% | 32.0% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 3.5% | 4.0% | 3.3% | 3.5% | 2.8% | 1.3% | 1.3% | 1.0% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 4.1% | 4.6% | 4.0% | 4.2% | 3.3% | 1.6% | 1.6% | 1.1% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 1.7 | 2.1 | 2.5 | 2.1 | 2.9 | 2.4 | 3.0 | 4.6 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 137,657 | 149,363 | 159,268 | 177,874 | 205,060 | 229,634 | 256,030 | 290,278 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Gintarinė vaistinė - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-01-16 | 2026-01-18 | 988.68 |
| 2025-03-18 | 2025-03-19 | 440.33 |
Gintarinė vaistinė - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Gintarine vaistine, UAB (code 125877727) is a Private Limited Liability Company engaged in the retail sale of pharmaceutical products. In 2025, the company generated revenue of €285.63M, up 16.0% year on year and 29.0% over two years. Net profit for 2025 was €2.84M, below €3.19M in 2024 and €2.90M in 2023, while the profit margin narrowed from 1.3% in 2023 and 2024 to 1.0% in 2025. The business therefore expanded strongly in sales, but profitability remained thin and slightly weaker in the latest year. Total assets increased from €32.61M in 2023 to €37.80M in 2024 and €51.07M in 2025. Equity stood at €8.87M in 2025, compared with €9.23M a year earlier, while liabilities rose to €40.69M from €27.58M. Key ratios for 2025 show ROE of 32.0%, ROA of 5.5%, debt-to-equity of 4.59, and asset turnover of 5.59x. Revenue per employee was €290.3K, with profit per employee of €2.9K.